206 related articles for article (PubMed ID: 25971575)
1. Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population.
Reddel HK; Sawyer SM; Everett PW; Flood PV; Peters MJ
Med J Aust; 2015 May; 202(9):492-7. PubMed ID: 25971575
[TBL] [Abstract][Full Text] [Related]
2. Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia.
Reddel HK; Beckert L; Moran A; Ingham T; Ampon RD; Peters MJ; Sawyer SM
Respirology; 2017 Nov; 22(8):1570-1578. PubMed ID: 28791752
[TBL] [Abstract][Full Text] [Related]
3. Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia.
Bosnic-Anticevich S; Kritikos V; Carter V; Yan KY; Armour C; Ryan D; Price D
J Asthma; 2018 Jun; 55(6):684-694. PubMed ID: 28886264
[TBL] [Abstract][Full Text] [Related]
4. Risks associated with managing asthma without a preventer: urgent healthcare, poor asthma control and over-the-counter reliever use in a cross-sectional population survey.
Reddel HK; Ampon RD; Sawyer SM; Peters MJ
BMJ Open; 2017 Sep; 7(9):e016688. PubMed ID: 28947448
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of asthma control by inhaled corticosteroids in general practice in Thailand.
Boonsawat W; Boonsawat W; Thinkhamrop B
Asian Pac J Allergy Immunol; 2015 Mar; 33(1):21-5. PubMed ID: 25840630
[TBL] [Abstract][Full Text] [Related]
6. Nebulizer use in inner-city children with asthma: morbidity, medication use, and asthma management practices.
Butz AM; Eggleston P; Huss K; Kolodner K; Rand C
Arch Pediatr Adolesc Med; 2000 Oct; 154(10):984-90. PubMed ID: 11030849
[TBL] [Abstract][Full Text] [Related]
7. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta
Azzi EA; Kritikos V; Peters MJ; Price DB; Srour P; Cvetkovski B; Bosnic-Anticevich S
BMJ Open; 2019 Aug; 9(8):e028995. PubMed ID: 31412998
[TBL] [Abstract][Full Text] [Related]
8. Risk factors hindering asthma symptom control in Saudi children and adolescents.
Halwani R; Vazquez-Tello A; Horanieh N; Dulgom S; Al-Aseri Z; Al-Khamis N; Al-Sum Z; Al-Jahdali H; Al-Muhsen S
Pediatr Int; 2017 Jun; 59(6):661-668. PubMed ID: 28218986
[TBL] [Abstract][Full Text] [Related]
9. Use of "preventer" medications and written asthma management plans among adults with asthma in New South Wales. NSW Health Department Asthma Data Working Group.
Marks GB; Jalaludin BB; Williamson M; Atkin NL; Bauman A
Med J Aust; 2000 Oct; 173(8):407-10. PubMed ID: 11090032
[TBL] [Abstract][Full Text] [Related]
10. Relationship between asthma drug therapy patterns and healthcare utilization.
Shireman TI; Heaton PC; Gay WE; Cluxton RJ; Moomaw CJ
Ann Pharmacother; 2002 Apr; 36(4):557-64. PubMed ID: 11918499
[TBL] [Abstract][Full Text] [Related]
11. A Web-Based and Mobile Health Social Support Intervention to Promote Adherence to Inhaled Asthma Medications: Randomized Controlled Trial.
Koufopoulos JT; Conner MT; Gardner PH; Kellar I
J Med Internet Res; 2016 Jun; 18(6):e122. PubMed ID: 27298211
[TBL] [Abstract][Full Text] [Related]
12. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
13. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial.
Rowe BH; Bota GW; Fabris L; Therrien SA; Milner RA; Jacono J
JAMA; 1999 Jun; 281(22):2119-26. PubMed ID: 10367823
[TBL] [Abstract][Full Text] [Related]
14. Asthma symptoms, morbidity, and antiinflammatory use in inner-city children.
Warman KL; Silver EJ; Stein RE
Pediatrics; 2001 Aug; 108(2):277-82. PubMed ID: 11483788
[TBL] [Abstract][Full Text] [Related]
15. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
[TBL] [Abstract][Full Text] [Related]
16. Childhood asthma control in Japan: A nationwide, cross-sectional, web-based survey.
Yoshida K; Sasaki M; Adachi Y; Itazawa T; Odajima H; Saito H; Akasawa A
Asian Pac J Allergy Immunol; 2018 Mar; 36(1):16-21. PubMed ID: 28577524
[TBL] [Abstract][Full Text] [Related]
17. Suboptimal asthma control: prevalence, detection and consequences in general practice.
Chapman KR; Boulet LP; Rea RM; Franssen E
Eur Respir J; 2008 Feb; 31(2):320-5. PubMed ID: 17959642
[TBL] [Abstract][Full Text] [Related]
18. Disease burden of mild asthma in China.
Ding B; Small M
Respirology; 2018 Apr; 23(4):369-377. PubMed ID: 29052915
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking and emergency care utilization among asthmatic adults in the 2011 Asthma Call-back Survey.
Khokhawalla SA; Rosenthal SR; Pearlman DN; Triche EW
J Asthma; 2015 Sep; 52(7):732-9. PubMed ID: 25563058
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]